Two Sigma Investments, LP X Biotech Inc. Transaction History

Two Sigma Investments, LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$4.03 - $8.13 $59,373 - $119,779	-14,733 Reduced 57.91%	10,707 $87,000
Q4 2023 Feb 14, 2024	SELL	$3.56 - $4.65 $19,224 - $25,110	-5,400 Reduced 17.51%	25,440 $101,000
Q3 2023 Nov 14, 2023	SELL	$4.02 - $5.81 $57,083 - $82,502	-14,200 Reduced 31.53%	30,840 $127,000
Q2 2023 Aug 14, 2023	SELL	$3.06 - $6.38 $30,284 - $63,142	-9,897 Reduced 18.02%	45,040 $267,000
Q1 2023 May 15, 2023	SELL	$3.22 - $4.72 $35,738 - $52,387	-11,099 Reduced 16.81%	54,937 $189,000
Q4 2022 Feb 14, 2023	SELL	$3.03 - $3.79 $33,514 - $41,921	-11,061 Reduced 14.35%	66,036 $231,000
Q3 2022 Nov 14, 2022	BUY	$3.58 - $5.88 $50,291 - $82,602	14,048 Added 22.28%	77,097 $279,000
Q2 2022 Aug 15, 2022	BUY	$5.13 - $9.2 $263,974 - $473,404	51,457 Added 443.9%	63,049 $355,000
Q1 2022 May 16, 2022	BUY	$8.64 - $11.71 $100,154 - $135,742	11,592 New	11,592 $100,000

4.87M

Ticker XBIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,439,300
Market Cap $203M
Description
XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical...

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Investments, LP with notifications on news.